Safety and Tolerability of BAY1862864 Injection in Subjects With Relapsed or Refractory CD22-positive Non-Hodgkin's Lymphoma

Clinical trial NCT02581878 · COMPLETED

Trial details

NCT number: NCT02581878
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma, Non-Hodgkin

Start date: 2015-11-20
Primary completion: 2019-11-11
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.